ATE102026T1 - Pankreatin-zubereitungen. - Google Patents
Pankreatin-zubereitungen.Info
- Publication number
- ATE102026T1 ATE102026T1 AT90122360T AT90122360T ATE102026T1 AT E102026 T1 ATE102026 T1 AT E102026T1 AT 90122360 T AT90122360 T AT 90122360T AT 90122360 T AT90122360 T AT 90122360T AT E102026 T1 ATE102026 T1 AT E102026T1
- Authority
- AT
- Austria
- Prior art keywords
- pancreatin
- mass
- solvent
- pancreatin preparations
- preparations
- Prior art date
Links
- 108010019160 Pancreatin Proteins 0.000 title abstract 3
- 229940055695 pancreatin Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 238000000605 extraction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
- 239000012798 spherical particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT268889 | 1989-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE102026T1 true ATE102026T1 (de) | 1994-03-15 |
Family
ID=3538711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90122360T ATE102026T1 (de) | 1989-11-24 | 1990-11-23 | Pankreatin-zubereitungen. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5674532A (de) |
| EP (1) | EP0436110B1 (de) |
| JP (1) | JP3025528B2 (de) |
| KR (1) | KR100229754B1 (de) |
| AT (1) | ATE102026T1 (de) |
| AU (1) | AU638784B2 (de) |
| CA (1) | CA2030581C (de) |
| DE (1) | DE69007055T2 (de) |
| DK (1) | DK0436110T3 (de) |
| ES (1) | ES2050340T3 (de) |
| HK (1) | HK102996A (de) |
| PH (1) | PH30058A (de) |
| WO (1) | WO1991007948A1 (de) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| SE9101090D0 (sv) * | 1991-04-11 | 1991-04-11 | Astra Ab | Process for conditioning of water-soluble substances |
| US5260074A (en) * | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| WO1996038169A1 (en) * | 1995-05-31 | 1996-12-05 | Akzo Nobel N.V. | Enteric coated compressed pancreatin particles |
| US5861291A (en) * | 1997-02-24 | 1999-01-19 | Biozymes Inc. | Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof |
| UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
| US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
| UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
| KR100367659B1 (ko) * | 2000-05-08 | 2003-01-14 | 주식회사 바이넥스 | 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법 |
| US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| US7153504B2 (en) * | 2004-07-30 | 2006-12-26 | Can Technologies, Inc. | Stabilized pancreas product |
| HUE031042T2 (en) | 2005-07-29 | 2017-06-28 | Abbott Laboratories Gmbh | Methods for producing pancreatin powder with low viral content |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| US8246950B2 (en) * | 2007-02-20 | 2012-08-21 | Aptalis Pharma Limited | Stable digestive enzyme compositions |
| US20090117180A1 (en) * | 2007-02-20 | 2009-05-07 | Giovanni Ortenzi | Stable digestive enzyme compositions |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
| US8084025B2 (en) * | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
| US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
| EP2318035B1 (de) | 2008-07-01 | 2019-06-12 | Curemark, Llc | Verfahren und zusammensetzungen zur behandlung von symptomen von neurologischen und geistesstörungen |
| US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| EP2165717A1 (de) | 2008-08-27 | 2010-03-24 | Nordmark Arzneimittel GmbH & Co.KG | Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte |
| US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
| WO2010080835A1 (en) | 2009-01-06 | 2010-07-15 | Curemark Llc | Compositions and methods for the treatment or the prevention oral infections by e. coli |
| CA2747611C (en) | 2009-01-06 | 2019-09-17 | Curemark Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
| BRPI0922653B8 (pt) | 2009-01-29 | 2021-05-25 | Nordmark Arzneimittel Gmbh & Co Kg | uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa |
| US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| EP2295039B2 (de) | 2009-08-28 | 2022-10-26 | Nordmark Pharma GmbH | Verfahren zur Herstellung von Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und hiernach hergestellte Pankreatin-Pellets |
| US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
| UA111726C2 (uk) | 2010-10-01 | 2016-06-10 | Апталіс Фарма Лімітед | Препарат панкреліпази низької сили з кишковорозчинним покриттям |
| DE202011000728U1 (de) | 2011-03-30 | 2011-06-09 | Nordmark Arzneimittel GmbH & Co. KG, 25436 | Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets |
| EP2489349B1 (de) | 2011-02-17 | 2014-05-28 | Nordmark Arzneimittel GmbH & Co.KG | Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets, und Verfahren zu deren Herstellung |
| JP5976100B2 (ja) | 2011-04-21 | 2016-08-23 | キュアマーク リミテッド ライアビリティ カンパニー | 神経精神障害の処置のための化合物 |
| CA2843556A1 (en) | 2011-08-08 | 2013-02-14 | Aptalis Pharma Ltd. | Method for dissolution testing of solid compositions containing digestive enzymes |
| US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
| MX2016001593A (es) | 2013-08-09 | 2016-09-29 | Allergan Pharmaceuticals Int Ltd | Composicion de enzima digestiva adecuada para administracion enterica. |
| JP2017519490A (ja) | 2014-06-19 | 2017-07-20 | アプタリス ファルマ リミテッド | 膵臓抽出物からのウイルス汚染の除去方法 |
| DE102015119006A1 (de) | 2015-11-05 | 2017-05-11 | Nordmark Arzneimittel Gmbh & Co. Kg | Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen |
| DE102017104482A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung umfassend Pankreatin und einen lipasehaltigen Überzug |
| US12226464B2 (en) | 2017-04-10 | 2025-02-18 | Curemark, Llc | Compositions for treating addiction |
| FR3079146B1 (fr) * | 2018-03-23 | 2020-04-17 | Karim Ioualalen | Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive. |
| MX2022014395A (es) * | 2020-06-10 | 2022-12-02 | Kusum Healthcare Pvt Ltd | Composicion farmaceutica de pancreatina. |
| US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3956483A (en) * | 1968-10-24 | 1976-05-11 | Wilson Pharmaceutical & Chemical Corporation | Preparing pancreatin |
| FR2059978A1 (en) * | 1969-08-20 | 1971-06-11 | Sogeras | Enteric coating of sensitive medicaments inp |
| JPS4946073B1 (de) * | 1970-04-08 | 1974-12-07 | ||
| JPS57791B2 (de) * | 1973-11-23 | 1982-01-07 | ||
| DE2512746C3 (de) * | 1975-03-22 | 1980-04-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin |
| GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| DE2923279C2 (de) * | 1979-06-08 | 1987-07-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel |
| EP0115023B1 (de) * | 1982-12-30 | 1988-07-27 | Nordmark Arzneimittel GmbH | Verfahren zur Gewinnung von Pankreatin |
| EP0166315B1 (de) * | 1984-06-19 | 1989-08-23 | BASF Aktiengesellschaft | Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten |
| DE3445301A1 (de) * | 1984-12-12 | 1986-06-12 | Hoechst Ag, 6230 Frankfurt | Pankreasenzympraeparate und verfahren zu deren herstellung |
-
1990
- 1990-11-22 KR KR1019900018928A patent/KR100229754B1/ko not_active Expired - Lifetime
- 1990-11-22 CA CA002030581A patent/CA2030581C/en not_active Expired - Lifetime
- 1990-11-22 PH PH41598A patent/PH30058A/en unknown
- 1990-11-22 JP JP2320550A patent/JP3025528B2/ja not_active Expired - Lifetime
- 1990-11-23 ES ES90122360T patent/ES2050340T3/es not_active Expired - Lifetime
- 1990-11-23 DK DK90122360.2T patent/DK0436110T3/da not_active Application Discontinuation
- 1990-11-23 AT AT90122360T patent/ATE102026T1/de not_active IP Right Cessation
- 1990-11-23 EP EP90122360A patent/EP0436110B1/de not_active Expired - Lifetime
- 1990-11-23 DE DE69007055T patent/DE69007055T2/de not_active Expired - Lifetime
- 1990-11-26 WO PCT/EP1990/002016 patent/WO1991007948A1/en not_active Ceased
- 1990-11-26 AU AU68701/91A patent/AU638784B2/en not_active Expired
-
1995
- 1995-06-06 US US08/466,303 patent/US5674532A/en not_active Expired - Lifetime
-
1996
- 1996-06-13 HK HK102996A patent/HK102996A/en not_active IP Right Cessation
-
1997
- 1997-06-19 US US08/879,240 patent/US5861177A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR910009282A (ko) | 1991-06-28 |
| WO1991007948A1 (en) | 1991-06-13 |
| DE69007055D1 (de) | 1994-04-07 |
| HK102996A (en) | 1996-06-21 |
| AU6870191A (en) | 1991-06-26 |
| DE69007055T2 (de) | 1994-08-25 |
| US5674532A (en) | 1997-10-07 |
| EP0436110A1 (de) | 1991-07-10 |
| JP3025528B2 (ja) | 2000-03-27 |
| JPH03172181A (ja) | 1991-07-25 |
| CA2030581C (en) | 2000-06-27 |
| AU638784B2 (en) | 1993-07-08 |
| DK0436110T3 (da) | 1994-06-20 |
| ES2050340T3 (es) | 1994-05-16 |
| KR100229754B1 (ko) | 1999-11-15 |
| PH30058A (en) | 1996-11-08 |
| EP0436110B1 (de) | 1994-03-02 |
| US5861177A (en) | 1999-01-19 |
| CA2030581A1 (en) | 1991-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE102026T1 (de) | Pankreatin-zubereitungen. | |
| DE68910051D1 (de) | Verfahren zur herstellung von aloe-erzeugnissen. | |
| ES8603753A1 (es) | Procedimiento de fabricacion de comprimidos efervescentes | |
| KR890011555A (ko) | 농축된 담배 추출물의 제조방법 | |
| HUT54885A (en) | Process for producing liofilized pharmaceutical compositions containing active components | |
| ATE268172T1 (de) | Verfahren zur herstellung von fenofibrat- präparaten | |
| ATE40647T1 (de) | Extraktionsverfahren von propolis, danach erhaltenes wasserloesliches getrocknetes pulver aus propolis, propolisenthaltende kosmetische und pharmazeutische praeparate. | |
| EP0380931A3 (de) | Verfahren zur kontinuierlichen Trocknung von hydrophilen Polymergelen | |
| SE9103372D0 (sv) | Saett och behaallare foer paaskyndande av upploesningen av svaarloesliga lyofiliserade vaevnadsklister | |
| IE41346B1 (en) | Preparation of meat analogues | |
| NO176645C (no) | Fremgangsmåte ved fremstilling av stabil frysetörket polyhematoporfyrineter/ester-blanding | |
| ATE86477T1 (de) | Galenische form eines trockenextraktes von pflanzen. | |
| EP0112563A3 (de) | Lösemittelbehandlung von Plasmaproteinprodukten | |
| DD152255A3 (de) | Vorrichtung zur mechanischen trockensortierung von heterogenem material,insbesondere von harten haushaltsabfaellen | |
| SE8705104D0 (sv) | Forfarande for utvinning av ballastemnen ur drav och derigenom framstelld produkt | |
| BG40805A3 (bg) | Метод за получаване на(s)-алфа-циан-3-феноксибензилов алкохол | |
| GR3007353T3 (de) | ||
| DK165738C (da) | Fremgangsmaade til granulering af vandoploeselige goedningsprodukter med hoejt kieseritindhold | |
| IL82937A (en) | 4-benzoyloxy-3-pyrrolin-2-on-1-yl acetamide,process for the preparation thereof and the use thereof | |
| JPS5239503A (en) | Method of drying metallurgical materials | |
| SU542762A1 (ru) | Способ выделени инвертазы из дрожжей | |
| TSAI et al. | Four new species of the genus Stylotermes Holmgren, K. et N.(Isoptera: Rhinotermitidae, Stylotermitinae) from Kwangsi | |
| EP0256695A3 (de) | Als knocheninduzierendes Mittel verwendbares Produkt und Verfahren zu seiner Herstellung | |
| DE3067343D1 (en) | Process for producing dry extract of colostrum, dry extract obtained and use thereof | |
| KR860000019A (ko) | 분말 녹차의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |